IGF1R POLYMORPHISM PREDICTS TUMOR RECURRENCE IN BREAST CANCER PATIENTS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20120289424A1
SERIAL NO

13468954

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure provides compositions and methods for determining the likely tumor recurrence in breast cancer patients by screening IGFR1 polymorphism in samples isolated from the patient.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF SOUTHERN CALIFORNIA1150 S OLIVE ST SUITE 2300 LOS ANGELES CA 90015

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lenz, Heinz-Josef Altadena, US 50 106
Stebbing, Justin London, GB 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation